Financhill
Back

Canaan, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
37

CAN
Canaan, Inc.

Last Price:
$0.95
Seasonality Move:
75.66%
Sell
30

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.63
Seasonality Move:
-20.14%
Sell
37
Canaan, Inc. (CAN) is a Sell

Is Canaan, Inc. a Buy, Sell or Hold?

  • The current Canaan, Inc. [CAN] share price is $0.93. The Score for CAN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • CAN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.50. The Score for INKT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CAN Stock Price Chart

What is Canaan, Inc.'s stock price today?

  • The Canaan, Inc. share price today is $0.93
    The current trend is relatively stagnant and CAN is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

CAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.35 Sell
Chaikin Money Flow: -11838012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.9 - 1.18) Sell
Bollinger Bands (100): (0.66 - 1.34) Sell

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 45.24 Sell
Chaikin Money Flow: -20001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.92 - 13.34) Sell
Bollinger Bands (100): (12.18 - 16.64) Sell

CAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.95 Sell
20-day SMA: 0.98 Sell
50-day SMA: 1.24 Sell
200-day SMA: 0.92 Buy
8-day EMA: 0.96 Sell
20-day EMA: 1.02 Sell
50-day EMA: 1.07 Sell
200-day EMA: 0.63 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.15 Buy
20-day SMA: 11.81 Sell
50-day SMA: 13.28 Sell
200-day SMA: 11.74 Sell
8-day EMA: 11.36 Buy
20-day EMA: 11.8 Sell
50-day EMA: 12.83 Sell
200-day EMA: 12.22 Sell

Canaan, Inc. Earnings Growth & CAN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.17 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Canaan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):